Press Releases - 2023-12-14

Date	Title	Company
14-Dec-2023	CellProthera advances towards its Phase III clinical trials with the development of a new potency assay	CellProthera
14-Dec-2023	Nottingham CRO Platelet Services marks fifth anniversary	Platelet Services
14-Dec-2023	U.S. IVD Market to Record an Exponential CAGR by 2032 – Exclusive Report by Allied Market Research	The Wire Times
14-Dec-2023	IBSA and Her Skipper Alberto Bona Win the 2023 Class40 Championship	Businesswire
14-Dec-2023	Biocomposites exceeds revenue expectations and takes a big step forward in its research and development	Biocomposites
14-Dec-2023	Engimmune Therapeutics strikes ‘fast-forward’ micro-fluidics collaboration with Swiss innovator CSEM	Engimmune Therapeutics
14-Dec-2023	SiSaf Announces Completion of Patient Enrolment in Phase II Trial of Bio-Courier® Drug Formulation for the Treatment of Mild/Moderate Alopecia Areata	SiSaf
14-Dec-2023	MitoRx Therapeutics Announces Close of Seed Extension Financing Round to Advance its Mitochondrial-Protective Therapeutics to Treat Degenerative Diseases	MitoRx Therapeutics
14-Dec-2023	HUTCHMED Announces that it has Completed Enrollment of a Phase II/III Trial of Fruquintinib in Combination with Sintilimab for Advanced Renal Cell Carcinoma in China	HUTCHMED
14-Dec-2023	DARZALEX® (daratumumab) Subcutaneous Formulation-Based Quadruplet Therapy Regimen Shows Significant Improvement in Outcomes for Patients with Transplant-Eligible Newly Diagnosed Multiple Myeloma	Janssen
14-Dec-2023	CellCentric discloses significant new clinical data, demonstrating inobrodib’s efficacy in ongoing Phase I/IIa clinical trials	CellCentric
14-Dec-2023	Blueprint Medicines’ AYVAKYT® (avapritinib) Receives European Commission Approval as the First and Only Treatment for Indolent Systemic Mastocytosis	Blueprint Medicines’ AYVAKYT® (avapritinib)
14-Dec-2023	Surgical Navigation Systems Market to Reach USD 1.75 Billion by 2030, exhibiting a CAGR of 6.4% from 2021 to 2030	The Wire Times
14-Dec-2023	ProBioGen Was Granted a New Patent for DirectedLuck® Transposase Technology	B3C newswire
14-Dec-2023	Fundraise, Update on Future Convertible Loan Note Financing and Total Voting Rights	Celadon Pharmaceuticals Plc
14-Dec-2023	STORM Therapeutics’ First-in-Class tRNA methyltransferase inhibitor of METTL1 to be Presented at the 65th Annual ASH Conference	STORM
14-Dec-2023	Modus Therapeutics presented data on sevuparin demonstrating its potential to treat anemia in chronic kidney disease at the annual American Society of Hematology (ASH)	Modus
14-Dec-2023	Families affected by ALS urged to join free program to uncover their genetic risk, contribute to research, and access new therapies	• Sano Genetics
14-Dec-2023	Samenvatting: Rapid Medical™ kondigt Japanse goedkeuring en exclusief partnerschap met Kaneka aan voor TIGERTRIEVER – 's werelds enige verstelbare trombectomieapparaat	Businesswire
14-Dec-2023	Riassunto: Rapid Medical™ annuncia l'autorizzazione giapponese e la collaborazione esclusiva con Kaneka per TIGERTRIEVER–l'unico dispositivo per trombectomia regolabile	Businesswire